Globus Medical Share Holder Equity 2010-2022 | GMED
Globus Medical share holder equity from 2010 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
- Globus Medical share holder equity for the quarter ending December 31, 2022 was $1.846B, a 6.03% increase year-over-year.
- Globus Medical share holder equity for 2022 was $1.846B, a 6.03% increase from 2021.
- Globus Medical share holder equity for 2021 was $1.741B, a 15.61% increase from 2020.
- Globus Medical share holder equity for 2020 was $1.506B, a 7.4% increase from 2019.
Globus Medical Annual Share Holder Equity
(Millions of US $) |
| 2022 |
$1,846 |
| 2021 |
$1,741 |
| 2020 |
$1,506 |
| 2019 |
$1,402 |
| 2018 |
$1,186 |
| 2017 |
$968 |
| 2016 |
$832 |
| 2015 |
$715 |
| 2014 |
$585 |
| 2013 |
$472 |
| 2012 |
$387 |
| 2011 |
$282 |
| 2010 |
$228 |
| 2009 |
$0 |
Globus Medical Quarterly Share Holder Equity
(Millions of US $) |
| 2022-12-31 |
$1,846 |
| 2022-09-30 |
$1,764 |
| 2022-06-30 |
$1,699 |
| 2022-03-31 |
$1,785 |
| 2021-12-31 |
$1,741 |
| 2021-09-30 |
$1,718 |
| 2021-06-30 |
$1,639 |
| 2021-03-31 |
$1,563 |
| 2020-12-31 |
$1,506 |
| 2020-09-30 |
$1,417 |
| 2020-06-30 |
$1,337 |
| 2020-03-31 |
$1,363 |
| 2019-12-31 |
$1,402 |
| 2019-09-30 |
$1,339 |
| 2019-06-30 |
$1,288 |
| 2019-03-31 |
$1,237 |
| 2018-12-31 |
$1,186 |
| 2018-09-30 |
$1,141 |
| 2018-06-30 |
$1,097 |
| 2018-03-31 |
$1,027 |
| 2017-12-31 |
$968 |
| 2017-09-30 |
$935 |
| 2017-06-30 |
$905 |
| 2017-03-31 |
$869 |
| 2016-12-31 |
$832 |
| 2016-09-30 |
$810 |
| 2016-06-30 |
$780 |
| 2016-03-31 |
$749 |
| 2015-12-31 |
$715 |
| 2015-09-30 |
$674 |
| 2015-06-30 |
$643 |
| 2015-03-31 |
$614 |
| 2014-12-31 |
$585 |
| 2014-09-30 |
$554 |
| 2014-06-30 |
$528 |
| 2014-03-31 |
$502 |
| 2013-12-31 |
$472 |
| 2013-09-30 |
$448 |
| 2013-06-30 |
$422 |
| 2013-03-31 |
$408 |
| 2012-12-31 |
$387 |
| 2012-09-30 |
$364 |
| 2012-06-30 |
$322 |
| 2012-03-31 |
$302 |
| 2011-12-31 |
$282 |
| 2011-09-30 |
$0 |
| 2011-06-30 |
$0 |
| 2011-03-31 |
$0 |
| 2010-12-31 |
$228 |
| 2009-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$5.255B |
$0.759B |
|
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
|
